nˌɛfɹoʊɾəksˈɪsᵻɾi — ˈɪŋkɹiːs ɪn sˈɛɹəm kɹiːˈeɪtɪnˌaɪn lˈɛvəlz ænd ɹˈiːnəl ˈɪndʒɚɹi kæn əkˈɜːɹ ɪn pˈeɪʃənts ɹᵻsˈiːvɪŋ fˈɑːskɑːɹnɪt.
Nephrotoxicity — increase in serum creatinine levels and renal injury can occur in patients receiving foscarnet.